Question Presented (from Petition)
Whether the Eighth Circuit erred in holding—in conflict with the decisions of other circuits and this Court—that a State may strip manufacturers of the ability preserved to them by 340B to impose conditions on the use of contract pharmacies as part of the offer to provide 340B-priced drugs and intrude on 340B's centralized enforcement scheme.
Question Presented (AI Summary)
Whether the Eighth Circuit erred in holding—in conflict with the decisions of other circuits and this Court—that a State may strip manufacturers of the ability preserved to them by 340B to impose conditions on the use of contract pharmacies as part of the offer to provide 340B-priced drugs and intrude on 340B's centralized enforcement scheme
2024-11-19
DISTRIBUTED for Conference of 12/6/2024.
2024-11-19
Reply of petitioner Pharmaceutical Research and Manufacturers of America filed. (Distributed)
2024-11-04
Brief of Community Health Centers of Arkansas and Piggott Community Hospital in opposition submitted.
2024-11-04
Brief of Alan McClain, Commissioner of the Arkansas Insurance Department, et al. in opposition submitted.
2024-11-04
Brief of respondents Community Health Centers of Arkansas and Piggott Community Hospital in opposition filed.
2024-11-04
Brief of respondents Alan McClain, Commissioner of the Arkansas Insurance Department, et al. in opposition filed.
2024-11-04
Brief of respondent Alan McClain, Commissioner of the Arkansas Insurance Department, in opposition filed.
2024-09-03
Amicus brief of Kalderos, Inc. submitted.
2024-09-03
Brief amicus curiae of Kalderos, Inc. filed.
2024-08-21
Motion to extend the time to file a response is granted and the time is extended to and including November 4, 2024.
2024-08-20
Motion of Alan McClain, Commissioner of the Arkansas Insurance Department, et al. for an extension of time submitted.
2024-08-20
Motion to extend the time to file a response from September 3, 2024 to November 4, 2024, submitted to The Clerk.
2024-07-31
Petition for a writ of certiorari filed. (Response due September 3, 2024)